Skip to content Skip to sidebar Skip to footer

OSCE Corrective Meeting in Dublin

Members of the IQPharm Project team from universities of Sarajevo, Banja Luka, Mostar, Novi Sad and Split attended the activities related to the development of Objective Structured Clinical Evaluation (OSCE) in Dublin, Ireland, at the School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin (TCD). The activities took place from December 12 to 14, 2022.

After the Pilot implementation of OSCE in Sarajevo in September, present activities in Dublin were corrective meetings on assessing and improving technical and organizational capacities and performing and post hoc evaluation of OSCE. Colleagues from Split gave critical overview of the Pilot implementation of OSCE. Hosts from TCD, as the institution with the longest and most advanced OSCE tradition, Dr Cathal Cadogan and Dr Theo Ryan presented the experiences of running OSCEs and provided valuable insights and advice on ways to improve organization and implementation of OSCE in Bosnia and Herzegovina in the future. These topics were extensively discussed by all participants in very inspiring meetings. Also, the delegation was brought on a tour of the facilities within the School of Pharmacy and Pharmaceutical Sciences, including the model pharmacy and consultatation skills room and concluded the visit with a tour of the Old Library and the Book of Kells.

Disclaimer: The European Commission’s support for the production of this website does not constitute an endorsement of the contents which reflects the views only of the authors, and the Commission’s cannot be held responsible for any use which may be made of the information contained therein.

IQPharm project is centered on raising the quality and modernization of pharmacy studies at public universities in Bosnia and Herzegovina including reinforcement of semi-structured experiential education (EE) in compliance with EU standards and regulations of higher education for regulated professions.

Newsletter

Join our newsletter and receive information about the IQPHARM project.

2021. IQPharm, All Rights Reserved

Project Reference: 618089-EPP-1-2020-1-BA-EPPKA2-CBHE-JP